Managing Germline Mutations in Hereditary Breast Cancer Risk
October 7th 2024Hereditary breast cancers are caused by germline mutations, which are genetic mutations inherited at conception and so called because they originate in germ cells, those that develop into reproductive cells and become eggs in female individuals and sperm in male individuals.
Read More
Dr Scott Manaker Looks to the Future of Physician Compensation at CHEST 2024
October 7th 2024One of the first sessions to kick off CHEST 2024 in Boston looked at the future of physician compensation, which highlighted the consolidation of physician practices, unionization, the role of coding and fee-for-service payment, and the impacts of facility reimbursement, inflation, and market conditions.
Watch
Air Pollution Increases IPF Exacerbations, but Role in Disease Progression Remains Uncertain
October 6th 2024Although air pollution is linked to increased exacerbations in patients with idiopathic pulmonary fibrosis (IPF), its role in disease progression remains uncertain, with evidence suggesting that both genetic susceptibility and environmental factors contribute to IPF development.
Read More
AI, Digital Technologies Set to Revolutionize COPD Care, Expert Says
October 6th 2024Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) and digital technologies to enhance treatment for chronic obstructive pulmonary disease (COPD) at the CHEST 2024 annual meeting in Boston, Massachusetts.
Read More
Expansion of Certified Community Behavioral Health Clinics Increases Access to Mental Health
October 4th 2024The extent to which certified community behavioral health clinic expansion reaches different parts of the country remained unclear until this study, which measured the proportion of US counties and populations within the service areas.
Read More
Real-World Data Support TKI Discontinuation After CP-CML Remission
October 4th 2024Most patients diagnosed with chronic-phase chronic myeloid leukemia (CP-CML) who achieved a deep molecular response on tyrosine kinase inhibitor (TKI) therapy were able to avoid relapse despite discontinuing therapy.
Read More
New Study Further Illuminates PARP1 Expression in ALL, AML, CML With BCR::ABL1 p190+
October 3rd 2024Researchers investigate the expression of PARP1 in leukemias with BCR::ABL1 p190+ translocation, finding differential expression in ALL, AML, and CML but no significant correlation with clinical parameters.
Read More
Addressing Trauma: A Vital Component in Behavioral Health
October 3rd 2024This interview accompanies the final podcast in our National Recovery Month series with Lyndra Bills, MD, senior medical director, and Shari Hutchison, MS, director of program evaluation and outcomes, both with Community Care Behavioral Health Organization, part of the UPMC Insurance Services Division.
Watch
The Spectrum of Pulmonary Disease: Dr Parth Rali Highlights CHEST 2024 Agenda
October 3rd 2024Parth Rali, MD, Temple University Hospital, is looking forward to approaching pulmonary vascular diseases as a spectrum, especially when assessing pulmonary embolism and pulmonary hypertension, at CHEST 2024.
Watch